VOR

NASDAQStock

Vor Biopharma Inc.

$13.51-0.54 (-3.84%)

52-Week Range

$3.03
$53.40

Key Stats

Market Cap

92.6M

P/E Ratio

Dividend Yield

Beta

2.04

Volume

531.0K

Avg Volume

681.1K

Performance

1M

+7.50%

3M

+4.00%

6M

-56.09%

YTD

+20.70%

1Y

-21.55%

3Y

-86.06%

5Y

-98.28%

Price Chart

ETF Exposure

VOR is held by 14 ETFs

ETFFund NameWeight
SURISimplify Propel Opportunities ETF0.45%
SBIO.LInvesco NASDAQ Biotech UCITS ETF0.02%
IBBQInvesco Nasdaq Biotechnology ETF0.02%
BIBProShares - Ultra Nasdaq Biotechnology0.01%
VXFVanguard Extended Market ETF0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%

About VOR ETF Exposure

Vor Biopharma Inc. (VOR) is held by 14 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 92.6M, VOR is a widely held institutional stock. The stock currently trades at $13.51. Investors can gain exposure to VOR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold VOR, sorted by portfolio weight.